JP2005522492A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522492A5
JP2005522492A5 JP2003583416A JP2003583416A JP2005522492A5 JP 2005522492 A5 JP2005522492 A5 JP 2005522492A5 JP 2003583416 A JP2003583416 A JP 2003583416A JP 2003583416 A JP2003583416 A JP 2003583416A JP 2005522492 A5 JP2005522492 A5 JP 2005522492A5
Authority
JP
Japan
Prior art keywords
group
methyl
pyridin
substituted
trimethoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003583416A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522492A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2003/004602 external-priority patent/WO2003086397A1/en
Publication of JP2005522492A publication Critical patent/JP2005522492A/ja
Publication of JP2005522492A5 publication Critical patent/JP2005522492A5/ja
Pending legal-status Critical Current

Links

JP2003583416A 2002-04-12 2003-04-11 癌治療薬 Pending JP2005522492A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37167502P 2002-04-12 2002-04-12
US41257102P 2002-09-23 2002-09-23
PCT/JP2003/004602 WO2003086397A1 (en) 2002-04-12 2003-04-11 Medicine for treating cancer

Publications (2)

Publication Number Publication Date
JP2005522492A JP2005522492A (ja) 2005-07-28
JP2005522492A5 true JP2005522492A5 (https=) 2006-01-05

Family

ID=29254452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003583416A Pending JP2005522492A (ja) 2002-04-12 2003-04-11 癌治療薬

Country Status (7)

Country Link
US (1) US20050176764A1 (https=)
EP (1) EP1494670A1 (https=)
JP (1) JP2005522492A (https=)
AU (1) AU2003222449A1 (https=)
MY (1) MY134200A (https=)
TW (1) TW200407141A (https=)
WO (1) WO2003086397A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20060040986A1 (en) * 2002-12-06 2006-02-23 Kowa Co., Ltd. Erythropoietin production accelerator
CA2518318A1 (en) 2003-03-17 2004-09-30 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP4634303B2 (ja) * 2003-10-10 2011-02-16 興和株式会社 血管新生抑制薬
US7521462B2 (en) 2004-02-27 2009-04-21 Eli Lilly And Company 4-Amino-piperidine derivatives as monoamine uptake inhibitors
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
WO2006082834A1 (ja) * 2005-02-02 2006-08-10 Kowa Co., Ltd. ケラチノサイト増殖に起因する疾患の予防・治療剤
US7642253B2 (en) 2005-05-11 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
WO2008044337A1 (en) * 2006-10-13 2008-04-17 Kowa Co., Ltd. γ-GLOBIN INDUCER
EP2520561B1 (en) 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
WO2010080864A1 (en) 2009-01-12 2010-07-15 Array Biopharma Inc. Piperidine-containing compounds and use thereof
EP2895474B1 (en) * 2012-09-17 2019-12-11 Duke University Smoothened receptor modulators and methods of use thereof
UY36391A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
US20190298705A1 (en) * 2016-06-08 2019-10-03 Glaxosmithkline Intellectual Property Development Limited Chemical Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3808921B2 (ja) * 1995-11-20 2006-08-16 興和株式会社 細胞接着阻害剤
US6605620B1 (en) * 2001-08-30 2003-08-12 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US6867221B2 (en) * 2001-08-30 2005-03-15 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US6395753B1 (en) * 2001-08-30 2002-05-28 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same

Similar Documents

Publication Publication Date Title
JP2005522492A5 (https=)
RU2397168C2 (ru) Производные тиофена в качестве ингибиторов снк 1
RU2004121161A (ru) Замещенные 2-тио-3,5-дициано-4-фенил-6-аминопиридины и их применение
RU2420522C2 (ru) Новый класс ингибиторов гистондеацетилаз
JP2005501120A5 (https=)
RU2004135066A (ru) Ингибиторы деацетилазы гистонов
JP2006515858A5 (https=)
CA2376305A1 (en) Sulfonamide and sulfamide substituted imidazoquinolines
JP2005511547A5 (https=)
RU2007107189A (ru) Производные арилпиридина
RU2001111023A (ru) Новые производные n-(иминометил)аминов, их получение, их использование в качестве лекарственных средств и содержащие их фармацевтические композиции
RU2009115653A (ru) Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения
NZ590355A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
JP2015510886A5 (https=)
JP2007016035A5 (https=)
RU2006116889A (ru) Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии
RU2004119406A (ru) 5-сульфанил-4н-1,2,4-триазольные производные и их применение в качестве лекарственного препарата
JP2012530765A5 (https=)
JPH10279578A5 (https=)
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
RU2010107603A (ru) Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний
JP2005511594A5 (https=)
JP2009520791A5 (https=)
JP2005527521A5 (https=)
JP2007514639A5 (https=)